LN PATTERNS AT THE ONSET OF PUBERTY.
In advanced puberty a pu!satlLc Lll pattern can be observed. In prepuberty absence of Lti pulses may be real or due to insensitivity of the LH assay. LH patterns were studied in healthy boys yr,BA:ll.O-11.5 yr,test.vol.(~v)<3 ml and 11 early pub. CA:11.5-13.4 yr, BA:11.0-12.5 yr, Tanner stage G2, TV)3 ml).Informed consent was obtained. Blood for LH estimation was sampled at 10' intervals from 12-10 hr and from 24-06 hr. A duoclonal IRMA, specific for LH wlth a sensitivity of 0.10 ~/ 1 (MAIAclone Serono) was used. In the G1 boys LA was not detectable during daytime; at night during periods of 20-60' detectable but low (<O.5 U/1) values were observed. In the G2 boys most diurnal values were> 0.3 U/1 with periods of values of 0.1-0.3 U/1; in 5 boys occasional pulses (<1.0 U/1 were observed. At night deflnite pulses up to 3 U/1 were observed In all boys; the median number of pulses was 4/6 hr.Conclusion: at the onset of puberty the still prepubertal boy has intermittant gonadotrophic activlty only during the n~g h t ; in early puberty thls actlvity increases to a clear pulsL%tlle Previously published information on GH metabolism in GH-defic i e n t p a t i e n t s i s s c a r c e and d a t a a r e c o n f l i c t i n g . We studied t h e metabolic clearance r'ate (MCR), plasma h a l f -l i f e and apparent d i s t r i b u t i o n space (DS) of u n l a b e l l e d ' m e t h i o n l n e f r e e 1 -b i o s y n t h e t i c human growth hormone (B-hGH) using t h e cons t a n t infusion technique in seven hypopituitary p a t i e n t s , 6 males and 1 female, mean age 21 years (range 15-29 years). They received a constant intravenous infusion of B-hGt1 with a r a t e of 50 ng/kg/min f o r t h r e e hours. After stopping t h e infusion t h e disappearance of se-growth hormone was followed f o r another t h r e e hours. The MCR averaged 4.06 ml/kg/min t 1.11 (SEM). T1/2 was estimated by means of l i n e a r regression a n a l y s i s , t h e mean value was 21.3 min t 2.14 (SEM). The elimination was found t o follow f i r s t order T i n e t i c s . The DS averaged 117.63 ml/kg t 26.93 (GEM). The present r e s u l t s demonstrate t h a t t h e kinetic; of B-hGH elimination i s of f i r s t order and f u r t h e r t h a t T1/2 i s of t h e same range a s described in normal subjects. 
Children's H o s p i t a l , U n i v e r s i t y o f W
i i r z b u r g , 56 D-8700 Wiirzburg, FRG. MONOMERIC SERUM CALCITONIN (M-CT) SECRETION DURING IIUMAN GROWTH IIORMONE (hGM) REPLACE- MENT OF GI<-DEFICIENT CHILDREN (GIID) .
hGI1 a d m i n i s t r a t i o n t o c h i l d r e n w i t h GllD i s a s s o c i a t e d w i t h i n c r e a s e d b o n e t u r n o v e r a n d t u b u l a r p h o s p h a t e ( P )
r e a b s o r p t i o n . B o t h m e c h a n i s m s a r e i m p o r t a n t f o r e n h e nc e d s o m a t i c g r o w t h a n d may b e r e g u l a t e d b y o t h e r f a ct o r s t h a n Gli o r SM-C. W e t h e r e f o r e s t u d i e d t h e r o l e of M-CT, t h e b i o l o g i c a l a c t i v e f o r m o f c a l c i t o n i n , a s a p o s s i b l e m e d i a t o r o f hGII o n P a n d b o n e m e t a b o l i s m . Ca s t i m u l a t e d ( 2 m g / k g / 5 m i n i v ) CT-M (ACT-M) w a s m e a s ur e d w i t h a new s i l i c a e x t r a c t i o n m e t h o d b e f o r e a n d d ur i n g hGH r e p l a c e m e n t i n 8 p r e p u b e r t a l c h i l d r e n w i t h G H i n c o m p a r i s o n t o 1 6 c o n t r o l s ( C ) a n d B c o n s t i t u t i o n a l t a l l c h i l d r e n (T).AM-CT mean's^^) w a s 3 6 2 1 0 i n u n t r e a t e d G f I D , 2'Ik4 i n C , a n d 14*4 p g / m l i n T (GIID v s T, P(O.05).
D u r i n g treatment w i t h 2 u / m 2 / d sc hG1tAM-CT d e c r e a s e d s i g n i f i c a n t l y i n GHD t o 16*4 p g / m l a
o l i n e a n d t ub u l a r t r a n s p o r t maximum f o r P (TmP/GFR), t h e l a t t e r ke i n g n e g a t i v e l y r e l a t e d t o A l 4 -C T ( r = -0 . 4 7 , n = 3 2 , P < 0 . 0 1 ) C o n c l u s i o n : hGII s u p p r e s s e s M-CT s e c r e t i o n , e x p l a i n i n g i n p a r t i t s i n c r e a s i n g e f f e c t o n b o n e t u r n o v e r a n d r e n a l p h o s p h a t e c o n s e r v a t i o n . 
IIYPOPITUITARY CIIILDREN
Adult height of hypopituitary children following treatment with human pltuitary growth hormone (hGH) is disappointingly low desplte the fact that hCH admlnistration before puberty results in accelerated statural growth without unduly accelerating bone maturation. Our study showed that the range of adult heights was similar for various types of hypopituitary growth retardation; thls range did not undergo an appreciable upward shift after hGH treatment.
Evaluation of hCH effectiveness for a well-deflned type, that of multiple pituitary hormone deficiency following breech birth, disclosed that adult height was not dependent on the presence of hGH (14 patlents wlth hGH averaged 162.9 cm (SEM 1 .9%), 1 0 patients without hGH 159.5 cm (SEM 3.49)).
Flowever, adult heights were reached at earller ages (with hGIi at 22.3 y (SEM .%8), wlthout hGH at 25.7 y (SEM . 5 4 ) ) . The duration of the pubertal spurt in growth brought about by androgen treatment was reduced by hCH from 9.5 y (SEM .91) to 5.5 y (SEM .45). Skeletal maturation must have been faster during androgen with hGll than durlng androgen alone. More detalled follow-up studies are needed, particularly in vlew of the Imminent rise In the number of patients that will undergo treatment wlth biosynthetic growth hormone.
Earlier treatment wlth higher or more frequent doses may be required to improve cffectlveness of CII on adult stature.
JOL. Jorgensen*, JS. Christiansen*, A. Flyvbjerg*, T. Lauritzen*, H. Orskov* (Introd. by N. Skakkeb~k). Second University C l i n i c of Internal Medicine. Aarhus. Kommunehospital, Aarhus, Denmark.
EVIDENCE OF LOCAL DEGRADATION OF SUBCUTANEOUSLY INJECTED BIOSYNTHETIC HUMAN GROWTH HORMONE IN HYPO-PITUITARY PATIENTS.
In a double-blind crossover study we coli~pared p i t u i t a r y and 'olethionine f r e e ' biosynthetic huii~an growth horr~~one (P-hGH and B-hGH) I n a p r e v i o u s study we observed t h a t ( s -c . ) with respect t o phar~ilacokinetics and s h o r t teml nptabolic e f f e c t s human growth ( h G H ) i n i n 9 hypopituitary childreA.They t r e a t e d themselves for 4 weeks lower Serum growth hormone p r o f i l e s (AUC) than a f t e r intramuswith 2 IU subcutaneously (s.c. ) d a i l y a t 20.00h. After adnlittance c u l a r~ ( ? -m e ) administration. In t h e Present study we compared to hospital 2 I U was g i v e n i n t r a n l u s c u l a r y (i.!".) the f i r s t day, t h e s t e a d y s t a t e serum concentrations of continuous infused and s . c . t h e second.They then switched over t o the a l t e r n a t i v e biosynthetic human growth hormone (B-hGH) v i a t h e S.C. and i.v. preparation.The pharnlacokinetics of 8-and p -h~~ were i d e n t i c a l .
r o u t e in 7 hypopituitary s u b j e c t s . 6 males and 1 female, mean Conlparing i.m. and 5.c. absorption ,the l a t t e r was slower,and reage 21 years (15-29) . The rate of B-hGH infusion was 50 ngfkgfs u l t e d i n smaller areas under the curves,indicating g r e a t e r local mi" I -v -infusion was performed f o r 3 hours* giving a mean degradation. Both preparations caused i d e n t i c a l increases i n somasteady s t a t e concentration of 17.3 ng/ml 2 3.3 (SEN). Following tomedin c , b u t s l i g h t l y more s u s t a i n e d s.c. i n j . p -g l u c o s e , a t h r e e h o u r s intermission t h e s.c. infusion was commenced -glukagon and 5-insulin f l u c t u a t e d within nornlal range.The glutl a s t i n g 19 hours and r e s u l t e d in s i g n i f i c a n t l y lower serum ose p r o f i l e pointed a t a n~odest a n t i -i n s u l i n e f f e c t of ~G H when conce"ration, 5.0 + 1.0 (SEMI ( P < 0.001). In four of given i n the morning.B-lactate,-alanine,-glycerol and -B -o H -~~-t h e s u b j e c t s t h e S.C. infusion was extended f o r a f u r t h e r 24 h tyrate,and s-TG,-cholesterol and -carbaolide revealed no abnormaw i t h a s t e a d y s t a t e mean serum concentration of 6 ng/ml ( P > l i t i e s with e i t h e r hGH preparation.Finally,no develop~i~ent of 0.2). These findings s t r o n g l y suggest a l o c a l s u b c u t a n e o u s anti-^^ or E c o l i polypeptide.antibodies was s e e n ,~R c o n c l u s i o n , degradation of i n j e c t e d hGH i n t h e s e s u b j e c t s . The e x a c t mechathe pharmacoki neti cs and s h o r t term metabolic e f f e c t s of 0-hGH nisms cannot be deduced from our r e s u l t s but must await f u r t h e r and P-hGH were identical.Furthermore,the advantage of d a i l y s . c .
investigationhGH i n j e c t i o n s i n the evening i s once more deinonstrated.
